Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Xhance™ (fluticasone propionate) for the Treatment of Nasal Polyps

Drug (Brand / Generic)

Xhance™ / fluticasone propionate

Developer

Optinose

Therapy Class

Synthetic trifluorinated corticosteroid

Current Indication

Nasal Polyps

Market Sector

Rhinology / otolaryngology (ENT)

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top